Evaluating non-drug methods to prevent dementia in elderly with mild cognitive impairment
Official title: Effectiveness of Dementia Prevention in Elderly Patients With Mild Cognitive Impairment at Nhân dân Gia Định Hospital, Hồ Chí Minh City
Run by Gia Dinh People Hospital · NCT06453746 · Data updated 2026-11-12
This study is testing a new program of simple brain exercises to see if it can help older adults with mild memory problems avoid getting dementia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 192 (estimated) |
| Sponsor | Gia Dinh People Hospital Academic / other |
| Locations | 1 site (Ho Chi Minh City) |
| Status | Recruiting |
| Started | August 26, 2024 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | September 19, 2024 |
| Trial ID | NCT06453746 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are elderly individuals diagnosed with mild cognitive impairment who can participate in cognitive training and have a supportive caregiver.
✕Probably not a fit
Patients with significant cognitive decline or those who do not speak Vietnamese may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effectiveness of a non-pharmacological intervention program designed to prevent the progression from mild cognitive impairment to dementia in elderly patients. The program includes home-based and supervised cognitive training exercises tailored to the Vietnamese population, addressing the unique cultural and linguistic needs of participants. By focusing on early-stage cognitive decline, the study seeks to leverage the remaining cognitive abilities of participants to maximize benefits. The interventions are designed to be user-friendly and accessible for the elderly, avoiding reliance on technology that may not be suitable for this demographic.
Why it matters
Potential benefit: If successful, this approach could provide a safe and effective means to delay or prevent the onset of dementia in at-risk elderly patients.
How similar studies have gone: While non-pharmacological interventions have been explored in other contexts, this specific approach tailored for the Vietnamese elderly population is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects diagnosed with mild cognitive impairment: * Cognitive complaints from the subject or a family member. * Report a decline in cognitive function compared to the subject's previous ability over the past year OR * Evidence from clinical assessment, specifically here is MMSE screening with results of 24-29 points. * Subjects did not suffer major impacts from cognitive complaints on daily life. * No prior diagnosis of dementia. * Ensure transportation from living location to hospital. * Have at least one relative or caregiver who can supervise the subject's daily activities. * Stable chronic underlying conditions (diabetes, hypertension). * Consent to participate in the study. Exclusion Criteria: * Don't know Vietnamese writing. * Audio-visual ability does not meet the requirements of assessment tests and prevention programs. * Systemic diseases are contraindications/ restriction to participation in programs and/or cause secondary cognitive impairment (traumatic brain injury, stroke, brain tumor, parkinsonism, epilepsy, acute coronary artery disease, acute myocardial infarction, bone fractures...). * The assessment score on the Geriatric Depression Scale (GDS-15) is ≥ 5 points. * Diagnosed with other mental disorders that may limit the ability to understand, communicate and work in groups (schizophrenia, mania, bipolar disorder, dissociative disorder, generalized anxiety disorder). * Currently participating in another research program on dementia prevention or a research program on medication to prevent dementia within the last 3 months. * Taking medications that may affect cognitive function, such as benzodiazepines, hypnotics, and antipsychotics. * Alcohol abuse: drinking alcohol daily or consuming more than 14 units of alcohol per week (equivalent to 10 grams of ethanol, as defined by the Ministry of Health); diagnosed with alcohol dependence or currently being treated for mental illness due to alcohol dependence. * Do not agree to participate in the study.
Where it's running
-
Nhân dân Gia Định Hospital
Ho Chi Minh City, Vietnam Recruiting
Study contacts
- Study coordinator: Khai Q. Nguyen, M.D
- Email: nguyenquangkhai2209@gmail.com
- Phone: +84704674558
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain Health PRO online program to reduce dementia risk
This online program tests whether a six‑month lifestyle education plan can help people aged 50–80 who are at risk for dementia reduce their risk factors.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Choose Myself (Before) Losing Myself
We’re testing an educational interactive booklet to help people with dementia or memory problems think about future medical decisions and start conversations with family or caregivers.
-
Gut and Oral Microbiome and Cognitive Health in Aging
This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
AI-supported sleep program for people with mild cognitive impairment or dementia
A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.